Partial V(D)J recombination activity leads to Omenn syndrome.

PubWeight™: 3.18‹?› | Rank: Top 1%

🔗 View Article (PMID 9630231)

Published in Cell on May 29, 1998

Authors

A Villa1, S Santagata, F Bozzi, S Giliani, A Frattini, L Imberti, L B Gatta, H D Ochs, K Schwarz, L D Notarangelo, P Vezzoni, E Spanopoulou

Author Affiliations

1: Department of Human Genome and Multifactorial Disease, Istituto di Tecnologie Biomediche Avanzate, Consiglio Nazionale delle Ricerche, Segrate (Milano) Italy.

Articles citing this

RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature (2007) 4.35

A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity (2007) 3.54

Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med (1998) 2.69

The RAG recombinase dictates functional heterogeneity and cellular fitness in natural killer cells. Cell (2014) 2.29

Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity (2007) 1.83

A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest (2005) 1.77

A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest (2007) 1.67

Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc Natl Acad Sci U S A (2007) 1.64

The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2. Mol Cell Biol (1999) 1.61

Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J Exp Med (2001) 1.59

A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest (2005) 1.54

A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol (2013) 1.48

Detection of RAG protein-V(D)J recombination signal interactions near the site of DNA cleavage by UV cross-linking. Mol Cell Biol (1999) 1.43

p110γ/δ Double-Deficiency Induces Eosinophilia and IgE Production but Protects from OVA-Induced Airway Inflammation. PLoS One (2016) 1.40

Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome. Blood (2009) 1.39

Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency. J Exp Med (2010) 1.35

AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest (2005) 1.35

Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency. Eur J Pediatr (2011) 1.33

N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains. Proc Natl Acad Sci U S A (2000) 1.32

Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J Clin Invest (2007) 1.32

Insertional translocation detected using FISH confirmation of array-comparative genomic hybridization (aCGH) results. Am J Med Genet A (2010) 1.31

Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet (1999) 1.27

Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr Opin Immunol (2014) 1.26

The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res (2001) 1.24

Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination. J Exp Med (2011) 1.24

Mutation analysis and embryonic expression of the HLXB9 Currarino syndrome gene. Am J Hum Genet (2000) 1.23

Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies. Mol Cell Biol (2000) 1.20

Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase. Mol Cell Biol (2002) 1.19

Impaired V(D)J recombination and lymphocyte development in core RAG1-expressing mice. J Exp Med (2003) 1.18

Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol (2003) 1.14

V(D)J recombination and the evolution of the adaptive immune system. PLoS Biol (2003) 1.14

Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development. J Allergy Clin Immunol (2014) 1.07

Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol (2010) 1.04

Omenn syndrome: a disorder of Rag1 and Rag2 genes. J Clin Immunol (1999) 1.03

Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome. J Exp Med (2010) 1.03

Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations. Blood (2007) 1.02

Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clin Exp Immunol (2008) 1.02

Variable phenotypic expression of mutations in genes of the immune system. J Clin Invest (2005) 1.02

Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am J Hum Genet (2002) 1.00

Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways. J Clin Invest (2002) 0.98

The molecular pathology of primary immunodeficiencies. J Mol Diagn (2004) 0.98

Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models. J Clin Immunol (2008) 0.97

Expanding the spectrum of recombination-activating gene 1 deficiency: a family with early-onset autoimmunity. J Allergy Clin Immunol (2013) 0.97

RAG2 is regulated differentially in B and T cells by elements 5' of the promoter. Proc Natl Acad Sci U S A (1999) 0.97

Adenovirus type F subtype 41 causing disseminated disease following bone marrow transplantation for immunodeficiency. J Clin Microbiol (2005) 0.90

Exome sequencing reveals RAG1 mutations in a child with autoimmunity and sterile chronic multifocal osteomyelitis evolving into disseminated granulomatous disease. J Clin Immunol (2013) 0.90

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest (2015) 0.90

Immunoglobulin class switch recombination: will genetics provide new clues to mechanism? Am J Hum Genet (1999) 0.89

A dual interaction between the DNA damage response protein MDC1 and the RAG1 subunit of the V(D)J recombinase. J Biol Chem (2012) 0.89

Abnormalities of thymic stroma may contribute to immune dysregulation in murine models of leaky severe combined immunodeficiency. Front Immunol (2011) 0.88

Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID. Clin Exp Med (2009) 0.87

Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders. Clin Exp Immunol (2000) 0.87

Lack of nonfunctional B-cell receptor rearrangements in a patient with normal B cell numbers despite partial RAG1 deficiency and atypical SCID/Omenn syndrome. J Clin Immunol (2008) 0.86

Severe combined immunodeficiency--molecular pathogenesis and diagnosis. Arch Dis Child (2001) 0.85

Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination. Mol Cell Biol (2001) 0.84

Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects. J Exp Med (2016) 0.84

RAG1 deficiency may present clinically as selective IgA deficiency. J Clin Immunol (2015) 0.83

Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency. Ital J Pediatr (2012) 0.81

Atypical X-linked SCID phenotype associated with growth hormone hyporesponsiveness. Clin Exp Immunol (2002) 0.80

Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications. Blood (2012) 0.80

The DNA-binding region of RAG 1 is not a homeodomain. Genome Biol (2002) 0.80

Omenn's Syndrome: A rare primary immunodeficiency disorder. Sultan Qaboos Univ Med J (2007) 0.80

The Extracellular Domains of IgG1 and T Cell-Derived IL-4/IL-13 Are Critical for the Polyclonal Memory IgE Response In Vivo. PLoS Biol (2015) 0.79

The role of genomics in common variable immunodeficiency disorders. Clin Exp Immunol (2017) 0.79

Murine models of Omenn syndrome. J Clin Invest (2007) 0.79

T-regulatory cells in primary immune deficiencies. Curr Opin Allergy Clin Immunol (2011) 0.79

Combined immunodeficiency evolving into predominant CD4+ lymphopenia caused by somatic chimerism in JAK3. J Clin Immunol (2014) 0.79

A RAG1 mutation found in Omenn syndrome causes coding flank hypersensitivity: a novel mechanism for antigen receptor repertoire restriction. J Immunol (2008) 0.79

Clinical Spectrum of SCID: The Key is in the Thymus? Front Immunol (2014) 0.78

Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia. BMC Med Genet (2009) 0.78

An interdomain boundary in RAG1 facilitates cooperative binding to RAG2 in formation of the V(D)J recombinase complex. Protein Sci (2015) 0.78

Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency. PLoS One (2014) 0.78

Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens. PLoS One (2015) 0.78

Omenn syndrome associated with a functional reversion due to a somatic second-site mutation in CARD11 deficiency. Blood (2015) 0.77

Genotype, phenotype, and outcomes of nine patients with T-B+NK+ SCID. Pediatr Transplant (2011) 0.77

Novel presentation of Omenn syndrome in association with aniridia. J Allergy Clin Immunol (2009) 0.77

Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies. Blood (2016) 0.77

Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience. J Clin Immunol (2014) 0.77

Rapid generation of novel models of RAG1 deficiency by CRISPR/Cas9-induced mutagenesis in murine zygotes. Oncotarget (2016) 0.77

High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). Biochem J (2005) 0.77

Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci Immunol (2016) 0.76

Temporal and spatial regulation of V(D)J recombination: interactions of extrinsic factors with the RAG complex. Adv Exp Med Biol (2009) 0.76

RAGs and BUGS: An alliance for autoimmunity. Gut Microbes (2016) 0.75

Primary immunodeficiencies associated with eosinophilia. Allergy Asthma Clin Immunol (2016) 0.75

Homozygous R396H mutation of the RAG1 gene in a Saudi infant with Omenn's syndrome: a case report. Cases J (2009) 0.75

Pathogen-sensing and regulatory T cells: integrated regulators of immune responses. Cancer Immunol Res (2014) 0.75

Co-existence of clonal expanded autologous and transplacental-acquired maternal T cells in recombination activating gene-deficient severe combined immunodeficiency. Clin Exp Immunol (2014) 0.75

Adapting to a changing world: RAG genomics and evolution. Hum Genomics (2005) 0.75

Impaired receptor editing and heterozygous RAG2 mutation in a patient with systemic lupus erythematosus and erosive arthritis. J Allergy Clin Immunol (2014) 0.75

Complete arrest from pro- to pre-B cells in a case of B cell-negative severe combined immunodeficiency (SCID) without recombinase activating gene (RAG) mutations. Clin Exp Immunol (2001) 0.75

Compound heterozygous mutation of Rag1 leading to Omenn syndrome. PLoS One (2015) 0.75

Mutations of the T-cell receptor constant region after in utero stem cell transplantation. Immunogenetics (2004) 0.75

Igf-I stimulates in vivo thymopoiesis after stem cell transplantation in a child with Omenn syndrome. J Clin Immunol (2009) 0.75

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A(+++) Cells, and Yet Display Increased Degranulation and Higher Perforin Content. Front Immunol (2017) 0.75

Cardiac thrombus in Omenn syndrome. Pediatr Cardiol (2005) 0.75

Articles by these authors

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet (2001) 15.27

Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell (2000) 9.99

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol (1999) 5.98

Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A (1985) 5.50

An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. J Immunol (1986) 5.14

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (1993) 4.39

Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell (1994) 4.04

Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet (1985) 3.83

Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr (1997) 3.63

The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro. Blood (1985) 3.53

Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet (2000) 3.12

DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell (1998) 2.97

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (1995) 2.93

FokI requires two specific DNA sites for cleavage. J Mol Biol (2001) 2.83

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science (1995) 2.79

Dispensable sequence motifs in the RAG-1 and RAG-2 genes for plasmid V(D)J recombination. Proc Natl Acad Sci U S A (1993) 2.65

Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest (1999) 2.58

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50

Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A (2001) 2.39

Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J (1998) 2.36

The homeodomain region of Rag-1 reveals the parallel mechanisms of bacterial and V(D)J recombination. Cell (1996) 2.36

Efficient correction for CT image artifacts caused by objects extending outside the scan field of view. Med Phys (2000) 2.35

Immune response after splenectomy. Lancet (1978) 2.31

RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination. Cell (1996) 2.31

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med (2000) 2.29

Monoclonal antibody-defined functional epitopes on the adhesion-promoting glycoprotein complex (CDw18) of human neutrophils. Blood (1986) 2.07

Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science (1996) 2.03

Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr (1982) 2.03

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet (1995) 2.03

Gastrointestinal manifestations of chronic granulomatous disease. N Engl J Med (1973) 1.99

CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A (1994) 1.94

Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol (1988) 1.91

The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91

Characterization of exogenous type D retrovirus from a fibroma of a macaque with simian AIDS and fibromatosis. Science (1984) 1.89

Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood (1998) 1.89

Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest (1996) 1.87

IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr (2001) 1.87

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med (2001) 1.86

T cell development in mice lacking the CD3-zeta/eta gene. EMBO J (1993) 1.84

Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity (1999) 1.79

Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood (1997) 1.77

Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest (1971) 1.76

A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome. Immunogenetics (2001) 1.72

Tissue-specific control elements of the Thy-1 gene. EMBO J (1990) 1.69

Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. 1951. Nutrition (1999) 1.68

Silicon, fibre, and atherosclerosis. Lancet (1977) 1.68

Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J Immunol (2001) 1.66

Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques. Pathologic observations and transmission studies. Am J Pathol (1985) 1.65

Implication of tubby proteins as transcription factors by structure-based functional analysis. Science (1999) 1.64

Absence of monoclonal-antibody-defined protein complex in boy with abnormal leucocyte function. Lancet (1984) 1.63

The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2. Mol Cell Biol (1999) 1.61

Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr (1985) 1.61

Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest (1990) 1.61

Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56

Effects of pentachlorophenol and some of its known and possible metabolites on different species of bacteria. Appl Environ Microbiol (1987) 1.55

Restricted expression of T cell receptor V beta but not V alpha genes in rheumatoid arthritis. Eur J Immunol (1991) 1.55

Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med (1977) 1.55

Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol (1997) 1.52

A new nucleotide-excision-repair gene associated with the disorder trichothiodystrophy. Am J Hum Genet (1993) 1.51

Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood (2001) 1.50

Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest (1998) 1.48

Xeroderma pigmentosum complementation group H falls into complementation group D. Mutat Res (1991) 1.48

Effect of antibodies directed against complement receptors on phagocytosis by polymorphonuclear leukocytes: use of iodination as a convenient measure of phagocytosis. J Immunol (1985) 1.47

Human monocyte adherence to cultured vascular endothelium: monoclonal antibody-defined mechanisms. J Immunol (1985) 1.46

Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency. J Pediatr (1974) 1.46

Genetic analysis of C4 deficiency. J Clin Invest (1981) 1.45

The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood (2001) 1.44

Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family. Clin Immunol (2001) 1.44

Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood (1981) 1.42

Metallic "ferroelectricity" in the pyrochlore Cd2Re2O7. Phys Rev Lett (2004) 1.42

Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr (2001) 1.41

Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest (1992) 1.41

Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med (1979) 1.41

Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency. N Engl J Med (1996) 1.40

Activated neutrophils disrupt endothelial monolayer integrity by an oxygen radical-independent mechanism. Lab Invest (1985) 1.40

Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol (2001) 1.39

Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest (1995) 1.39

Correlation induced paramagnetic ground state in FeAl. Phys Rev Lett (2001) 1.39

Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol Cell Biol (2000) 1.38

Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant (2010) 1.38

Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol (1998) 1.37

Phosphorylation of the oxidase-related 48K phosphoprotein family in the unusual autosomal cytochrome-negative and X-linked cytochrome-positive types of chronic granulomatous disease. Blood (1988) 1.36

Detection of clonal T cell populations with closely related T cell receptor junctional sequences in persons at high risk for human immunodeficiency virus (HIV) infection and in patients acutely infected with HIV. J Infect Dis (1997) 1.35

What is metamorphosis? Integr Comp Biol (2006) 1.35

The RAG1/RAG2 complex constitutes a 3' flap endonuclease: implications for junctional diversity in V(D)J and transpositional recombination. Mol Cell (1999) 1.35

B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med (1993) 1.35